$3.81+1.06%
2026-10-06 closePrelude Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was $7M. 2024 operating profit was −$140M.
Reported results
Quantus Signal · live data · not investment advice · Privacy Policy
Prelude Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was $7M. 2024 operating profit was −$140M.